Trials / Completed
CompletedNCT02062658
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | 0.5mg/kg IV |
| BEHAVIORAL | Exposure and Response Prevention | A type of Cognitive Behavioral Therapy called Exposure and Response Prevention. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-02-14
- Last updated
- 2016-12-29
- Results posted
- 2016-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02062658. Inclusion in this directory is not an endorsement.